Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 0904-7506

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 0904-7506). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

500mg Carton Label (6166c40c 4fbe 47c4 92e4 2dc5d3567a86 00)

Ranolazine Extended-Release Tablets 500 mg film-coated oral tablets by Major Pharmaceuticals. The label indicates the unit dose packaging containing 30 tablets (3 x 10). It includes directions to swallow whole without crushing, breaking, or chewing, storage instructions, and institutional use warnings. The label shows NDC 0904-7506-04 and contact information for Major Pharmaceuticals in Indianapolis, IN.*

FDA Label Image

Ranolazine-structure (Ranolazine Structure)

Chemical structure diagram of ranolazine, showing its molecular composition with various functional groups including hydroxyl and methoxy groups as part of the extended structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.